A comprehensive in silico and in vitro studies on quinizarin : a promising phytochemical derived from Rhizophora mucronata Lam

Mangrove plants are a great source of phytomedicines, since from the beginning of human civilization and the origin of traditional medicines. In the present study, ten different mangrove leaf methanolic extracts were screened for the type of phytochemicals followed by assessing antimicrobial, anti-oxidant and anti-cancer activities. The efficient methanolic crude extract of Rhizospora mucornata was further purified and characterized for the presence of the bioactive compound. Based on UV-visible spectroscopy, FTIR, NMR and HRMS analysis, the bioactive compound was 1,4-dihydroanthraquinone; also termed as Quinizarin. This identified compound was potential in exhibiting antimicrobial, antioxidant, and cytotoxic activity. Quinizarin inhibited the growth of Bacillus cereus and Klebsiella aerogenes with minimum inhibitory concentration (MIC) of 0.78 and 1.5 mg/ml. The DPPH free radical scavenging assay revealed the maximum activity of 99.8% at the concentration of 200 µg/ml with an IC50 value of 12.67 ± 0.41 µg/ml. Cytotoxic assay against HeLa (cervical) and MDA-MB231(breast) cancer cell lines revealed IC50 values to be 4.60 ± 0.26 and 3.89 ± 0.15 µg/ml. Together the results of molecular docking and molecular dynamics simulation studies explained that Quinizarin molecule showed stronger binding affinity (-6.2 kcal/mol) and significant structural stability towards anti-apoptotic Bcl-2 protein. Thus, the study put forth the promising role of the natural molecule - Quinizarin isolated from R. mucornata in the formulation of therapeutic drugs against bacterial infections and cancer. Communicated by Ramaswamy H. Sarma.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

Journal of biomolecular structure & dynamics - 40(2022), 16 vom: 03. Okt., Seite 7218-7229

Sprache:

Englisch

Beteiligte Personen:

Sachithanandam, V [VerfasserIn]
Lalitha, P [VerfasserIn]
Parthiban, A [VerfasserIn]
Muthukumaran, Jayaraman [VerfasserIn]
Jain, Monika [VerfasserIn]
Misra, Ranjita [VerfasserIn]
Mageswaran, T [VerfasserIn]
Sridhar, R [VerfasserIn]
Purvaja, R [VerfasserIn]
Ramesh, R [VerfasserIn]

Links:

Volltext

Themen:

1,4-dihydroxyanthraquinone
8S496ZV3CS
Anthraquinones
Anti-Bacterial Agents
Anti-Infective Agents
Antioxidants
Cytotoxicity
Journal Article
Mangrove plants
Molecular docking
Molecular dynamics simulation
Phytochemicals
Plant Extracts
Quinizarin
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 13.09.2022

Date Revised 12.10.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/07391102.2021.1894983

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM322398525